Boston Scientific shares closed at $64.87, up 8.99%, after a Q1 earnings beat. The reaction is tempered by lowered 2026 guidance, which resets longer-term growth expectations and could pressure valuation multiples. Investors are focused on whether the revised targets still support the current rally.
Boston Scientific shares closed at $64.87, up 8.99%, after a Q1 earnings beat. The reaction is tempered by lowered 2026 guidance, which resets longer-term growth expectations and could pressure valuation multiples. Investors are focused on whether the revised targets still support the current rally.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
mildly positive
Sentiment Score
0.15
Ticker Sentiment
